{"transactions":[{"id":352019,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-03-03T00:23:39.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":6247,"price":99.77,"value":623263.19,"ownership":{"direct":true},"balance_after":339443,"source":{"system":"sec-edgar","filing":"0001415889-23-003897","document":"form4-03032023_120325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003897/form4-03032023_120325.xml","form_type":"4"}},{"id":352764,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2023-02-22T23:43:25.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":62527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 20,842 on February 17, 2024, 20,842 on February 17, 2025, and 20,843 on February 17, 2026."}],"balance_after":62527,"derivative":{"exercise_price":106.24,"exercise_date":"2024-02-17","expiration_date":"2033-02-16","underlying":"Common Shares","underlying_shares":62527},"source":{"system":"sec-edgar","filing":"0001415889-23-003048","document":"form4-02222023_110254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003048/form4-02222023_110254.xml","form_type":"4"}},{"id":352763,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-02-22T23:43:25.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":15855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":345690,"source":{"system":"sec-edgar","filing":"0001415889-23-003048","document":"form4-02222023_110254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003048/form4-02222023_110254.xml","form_type":"4"}},{"id":364711,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-03-03T00:35:09.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":7086,"price":122.41,"value":867397.26,"ownership":{"direct":true},"balance_after":329835,"source":{"system":"sec-edgar","filing":"0001415889-22-002188","document":"form4-03022022_040351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922002188/form4-03022022_040351.xml","form_type":"4"}},{"id":365295,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2022-02-24T01:04:06.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":72342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 24,114 on February 18, 2023, 24,114 on February 18, 2024, and 24,114 on February 18, 2025."}],"balance_after":72342,"derivative":{"exercise_price":117.58,"exercise_date":"2023-02-18","expiration_date":"2032-02-17","underlying":"Common Shares","underlying_shares":72342},"source":{"system":"sec-edgar","filing":"0001415889-22-001732","document":"form4-02232022_050247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001732/form4-02232022_050247.xml","form_type":"4"}},{"id":365294,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-02-24T01:04:06.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":15523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":336921,"source":{"system":"sec-edgar","filing":"0001415889-22-001732","document":"form4-02232022_050247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001732/form4-02232022_050247.xml","form_type":"4"}},{"id":368598,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-12-15T23:32:08.000Z","date":"2021-12-13","kind":"exercise","acquired":false,"shares":149600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":34.94,"exercise_date":"2016-02-15","expiration_date":"2023-02-14","underlying":"Common Shares","underlying_shares":149600},"source":{"system":"sec-edgar","filing":"0001415889-21-005966","document":"form4-12152021_031259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921005966/form4-12152021_031259.xml","form_type":"4"}},{"id":368597,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-12-15T23:32:08.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":149600,"price":135.0515,"value":20203704.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.295 inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":321398,"source":{"system":"sec-edgar","filing":"0001415889-21-005966","document":"form4-12152021_031259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921005966/form4-12152021_031259.xml","form_type":"4"}},{"id":368596,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-12-15T23:32:08.000Z","date":"2021-12-13","kind":"exercise","acquired":true,"shares":149600,"price":34.94,"value":5227024.0,"ownership":{"direct":true},"balance_after":470998,"source":{"system":"sec-edgar","filing":"0001415889-21-005966","document":"form4-12152021_031259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921005966/form4-12152021_031259.xml","form_type":"4"}},{"id":379025,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-03-03T00:08:09.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":9267,"price":121.58,"value":1126681.86,"ownership":{"direct":true},"balance_after":321398,"source":{"system":"sec-edgar","filing":"0001415889-21-001199","document":"form4-03022021_040356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921001199/form4-03022021_040356.xml","form_type":"4"}},{"id":379673,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-02-23T23:34:20.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":71070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 23,690 on February 19, 2022, 23,690 on February 19, 2023, and 23,690 on February 19, 2024."}],"balance_after":71070,"derivative":{"exercise_price":124.04,"exercise_date":"2022-02-19","expiration_date":"2031-02-18","underlying":"Common Shares","underlying_shares":71070},"source":{"system":"sec-edgar","filing":"0001415889-21-000887","document":"form4-02232021_030259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000887/form4-02232021_030259.xml","form_type":"4"}},{"id":379672,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-02-23T23:34:20.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":13865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":330665,"source":{"system":"sec-edgar","filing":"0001415889-21-000887","document":"form4-02232021_030259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000887/form4-02232021_030259.xml","form_type":"4"}},{"id":386721,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2020-08-31T22:27:20.000Z","date":"2020-08-27","kind":"exercise","acquired":false,"shares":52300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":27.0336,"exercise_date":"2015-02-17","expiration_date":"2022-02-16","underlying":"Common shares","underlying_shares":52300},"source":{"system":"sec-edgar","filing":"0001179110-20-009446","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020009446/edgar.xml","form_type":"4"}},{"id":386720,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-08-31T22:27:20.000Z","date":"2020-08-27","kind":"sale","acquired":false,"shares":52300,"price":111.86,"value":5850278.0,"ownership":{"direct":true},"balance_after":316800,"source":{"system":"sec-edgar","filing":"0001179110-20-009446","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020009446/edgar.xml","form_type":"4"}},{"id":386719,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-08-31T22:27:20.000Z","date":"2020-08-27","kind":"exercise","acquired":true,"shares":52300,"price":27.0336,"value":1413857.28,"ownership":{"direct":true},"balance_after":369100,"source":{"system":"sec-edgar","filing":"0001179110-20-009446","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020009446/edgar.xml","form_type":"4"}},{"id":391642,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2020-04-24T01:34:24.000Z","date":"2020-04-21","kind":"exercise","acquired":false,"shares":50100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":22.3919,"exercise_date":"2014-02-18","expiration_date":"2021-02-17","underlying":"Common shares","underlying_shares":50100},"source":{"system":"sec-edgar","filing":"0001179110-20-005070","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020005070/edgar.xml","form_type":"4"}},{"id":391641,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-04-24T01:34:24.000Z","date":"2020-04-21","kind":"sale","acquired":false,"shares":18701,"price":96.2834,"value":1800595.8634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.14 to $96.52, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":316800,"source":{"system":"sec-edgar","filing":"0001179110-20-005070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020005070/edgar.xml","form_type":"4"}},{"id":391640,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-04-24T01:34:24.000Z","date":"2020-04-21","kind":"sale","acquired":false,"shares":31399,"price":95.6314,"value":3002730.3286,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.14 to $96.135, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":335501,"source":{"system":"sec-edgar","filing":"0001179110-20-005070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020005070/edgar.xml","form_type":"4"}},{"id":391639,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-04-24T01:34:24.000Z","date":"2020-04-21","kind":"exercise","acquired":true,"shares":50100,"price":22.3919,"value":1121834.19,"ownership":{"direct":true},"balance_after":366900,"source":{"system":"sec-edgar","filing":"0001179110-20-005070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020005070/edgar.xml","form_type":"4"}},{"id":393942,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-03-03T22:25:30.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":8704,"price":79.19,"value":689269.76,"ownership":{"direct":true},"balance_after":316800,"source":{"system":"sec-edgar","filing":"0001179110-20-002915","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002915/edgar.xml","form_type":"4"}},{"id":394490,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2020-02-25T22:27:04.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":103446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 34,482 on February 21, 2021, 34,482 on February 21, 2022, and 34,482 on February 21, 2023."}],"balance_after":103446,"derivative":{"exercise_price":87.72,"exercise_date":"2021-02-21","expiration_date":"2030-02-20","underlying":"Common shares","underlying_shares":103446},"source":{"system":"sec-edgar","filing":"0001179110-20-002279","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002279/edgar.xml","form_type":"4"}},{"id":394489,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2020-02-25T22:27:04.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":16969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":325504,"source":{"system":"sec-edgar","filing":"0001179110-20-002279","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002279/edgar.xml","form_type":"4"}},{"id":401948,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2019-06-21T21:20:05.000Z","date":"2019-06-20","kind":"exercise","acquired":false,"shares":46900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":26.1879,"exercise_date":"2013-02-19","expiration_date":"2020-02-18","underlying":"Common shares","underlying_shares":46900},"source":{"system":"sec-edgar","filing":"0001179110-19-008035","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019008035/edgar.xml","form_type":"4"}},{"id":401947,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-06-21T21:20:05.000Z","date":"2019-06-20","kind":"sale","acquired":false,"shares":46900,"price":85,"value":3986500.0,"ownership":{"direct":true},"balance_after":308535,"source":{"system":"sec-edgar","filing":"0001179110-19-008035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019008035/edgar.xml","form_type":"4"}},{"id":401946,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-06-21T21:20:05.000Z","date":"2019-06-20","kind":"exercise","acquired":true,"shares":46900,"price":26.1879,"value":1228212.51,"ownership":{"direct":true},"balance_after":355435,"source":{"system":"sec-edgar","filing":"0001179110-19-008035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019008035/edgar.xml","form_type":"4"}},{"id":406320,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-03-04T22:21:40.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":9132,"price":77.23,"value":705264.36,"ownership":{"direct":true},"balance_after":308535,"source":{"system":"sec-edgar","filing":"0001179110-19-003112","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019003112/edgar.xml","form_type":"4"}},{"id":406874,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2019-02-26T22:06:23.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":101519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 33,839 on February 22, 2020, 33,840 on February 22, 2021, and 33,840 on February 22, 2022."}],"balance_after":101519,"derivative":{"exercise_price":75.9,"exercise_date":"2020-02-22","expiration_date":"2029-02-21","underlying":"Common shares","underlying_shares":101519},"source":{"system":"sec-edgar","filing":"0001179110-19-002638","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019002638/edgar.xml","form_type":"4"}},{"id":406873,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2019-02-26T22:06:23.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":19367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":317667,"source":{"system":"sec-edgar","filing":"0001179110-19-002638","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911019002638/edgar.xml","form_type":"4"}},{"id":413264,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2018-07-26T21:05:20.000Z","date":"2018-07-25","kind":"exercise","acquired":false,"shares":64900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":26.015,"exercise_date":"2012-02-20","expiration_date":"2019-02-19","underlying":"Common shares","underlying_shares":64900},"source":{"system":"sec-edgar","filing":"0001179110-18-009933","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018009933/edgar.xml","form_type":"4"}},{"id":413263,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2018-07-26T21:05:20.000Z","date":"2018-07-25","kind":"sale","acquired":false,"shares":64900,"price":65,"value":4218500.0,"ownership":{"direct":true},"balance_after":298300,"source":{"system":"sec-edgar","filing":"0001179110-18-009933","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018009933/edgar.xml","form_type":"4"}},{"id":413262,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2018-07-26T21:05:20.000Z","date":"2018-07-25","kind":"exercise","acquired":true,"shares":64900,"price":26.015,"value":1688373.5,"ownership":{"direct":true},"balance_after":363200,"source":{"system":"sec-edgar","filing":"0001179110-18-009933","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018009933/edgar.xml","form_type":"4"}},{"id":417553,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2018-03-02T22:10:29.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":7958,"price":60.55,"value":481856.9,"ownership":{"direct":true},"balance_after":298300,"source":{"system":"sec-edgar","filing":"0001179110-18-003301","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018003301/edgar.xml","form_type":"4"}},{"id":418539,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2018-02-21T23:36:57.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":155495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 51,832 on 02/16/2019, 51,831 on 02/16/2020, and 51,832 on 02/16/2021."}],"balance_after":155495,"derivative":{"exercise_price":59.94,"exercise_date":"2019-02-16","expiration_date":"2028-02-15","underlying":"Common shares","underlying_shares":155495},"source":{"system":"sec-edgar","filing":"0001179110-18-002532","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018002532/edgar.xml","form_type":"4"}},{"id":418538,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2018-02-21T23:36:57.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":28276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":306258,"source":{"system":"sec-edgar","filing":"0001179110-18-002532","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911018002532/edgar.xml","form_type":"4"}},{"id":429023,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-03-02T22:14:30.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":10815,"price":45.46,"value":491649.9,"ownership":{"direct":true},"balance_after":277982,"source":{"system":"sec-edgar","filing":"0001179110-17-003677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017003677/edgar.xml","form_type":"4"}},{"id":429739,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2017-02-22T22:57:52.000Z","date":"2017-02-21","kind":"exercise","acquired":true,"shares":93400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":26.6973,"exercise_date":"2011-02-08","expiration_date":"2018-02-14","underlying":"Common shares","underlying_shares":93400},"source":{"system":"sec-edgar","filing":"0001179110-17-002952","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017002952/edgar.xml","form_type":"4"}},{"id":429738,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2017-02-22T22:57:52.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":98714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 32,905 on 2/17/2018, 32,904 on 2/17/2019, and 32,905 on 2/17/2020."}],"balance_after":98714,"derivative":{"exercise_price":44.4,"exercise_date":"2018-02-17","expiration_date":"2027-02-16","underlying":"Common shares","underlying_shares":98714},"source":{"system":"sec-edgar","filing":"0001179110-17-002952","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017002952/edgar.xml","form_type":"4"}},{"id":429737,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-02-22T22:57:52.000Z","date":"2017-02-21","kind":"sale","acquired":false,"shares":93400,"price":45,"value":4203000.0,"ownership":{"direct":true},"balance_after":288797,"source":{"system":"sec-edgar","filing":"0001179110-17-002952","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017002952/edgar.xml","form_type":"4"}},{"id":429736,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-02-22T22:57:52.000Z","date":"2017-02-21","kind":"exercise","acquired":true,"shares":93400,"price":26.6973,"value":2493527.82,"ownership":{"direct":true},"balance_after":382197,"source":{"system":"sec-edgar","filing":"0001179110-17-002952","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017002952/edgar.xml","form_type":"4"}},{"id":429735,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2017-02-22T22:57:52.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":14273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":288797,"source":{"system":"sec-edgar","filing":"0001179110-17-002952","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911017002952/edgar.xml","form_type":"4"}},{"id":433396,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2016-11-18T22:02:03.000Z","date":"2016-11-16","kind":"exercise","acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":24.3812,"exercise_date":"2010-08-01","expiration_date":"2017-07-31","underlying":"Common shares","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001179110-16-031866","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016031866/edgar.xml","form_type":"4"}},{"id":433395,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2016-11-18T22:02:03.000Z","date":"2016-11-16","kind":"exercise","acquired":true,"shares":22000,"price":24.3812,"value":536386.4,"ownership":{"direct":true},"balance_after":274524,"source":{"system":"sec-edgar","filing":"0001179110-16-031866","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016031866/edgar.xml","form_type":"4"}},{"id":441039,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2016-03-02T22:53:50.000Z","date":"2016-02-29","kind":"tax_withholding","acquired":false,"shares":9980,"price":39.52,"value":394409.6,"ownership":{"direct":true},"balance_after":252524,"source":{"system":"sec-edgar","filing":"0001179110-16-020707","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016020707/edgar.xml","form_type":"4"}},{"id":441612,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2016-02-23T23:02:06.000Z","date":"2016-02-19","kind":"grant","acquired":true,"shares":214041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 71,347 on 02/19/2017, 71,347 on 02/19/2018, and 71,347 on 02/19/2019."}],"balance_after":214041,"derivative":{"exercise_price":38.4,"exercise_date":"2017-02-19","expiration_date":"2026-02-18","underlying":"Common shares","underlying_shares":214041},"source":{"system":"sec-edgar","filing":"0001179110-16-019916","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016019916/edgar.xml","form_type":"4"}},{"id":441611,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2016-02-23T23:02:06.000Z","date":"2016-02-19","kind":"grant","acquired":true,"shares":24414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":262504,"source":{"system":"sec-edgar","filing":"0001179110-16-019916","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911016019916/edgar.xml","form_type":"4"}},{"id":454121,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-03-03T22:12:02.000Z","date":"2015-02-27","kind":"tax_withholding","acquired":false,"shares":12312,"price":47.61,"value":586174.32,"ownership":{"direct":true},"balance_after":238090,"source":{"system":"sec-edgar","filing":"0001179110-15-004034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015004034/edgar.xml","form_type":"4"}},{"id":454750,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2015-02-24T23:31:28.000Z","date":"2015-02-20","kind":"grant","acquired":true,"shares":165292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 55,098 on 2/20/16, 55,097 on 2/20/17, and 55,097 on 2/20/18."}],"balance_after":165292,"derivative":{"exercise_price":47,"exercise_date":"2016-02-20","expiration_date":"2025-02-19","underlying":"Common shares","underlying_shares":165292},"source":{"system":"sec-edgar","filing":"0001179110-15-003367","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015003367/edgar.xml","form_type":"4"}},{"id":454749,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-24T23:31:28.000Z","date":"2015-02-20","kind":"grant","acquired":true,"shares":23457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes."}],"balance_after":250402,"source":{"system":"sec-edgar","filing":"0001179110-15-003367","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015003367/edgar.xml","form_type":"4"}},{"id":456082,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:12:36.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":400,"price":45.86,"value":18344.0,"ownership":{"direct":true},"balance_after":226945,"source":{"system":"sec-edgar","filing":"0001179110-15-002009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002009/edgar.xml","form_type":"4"}},{"id":456081,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:12:36.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":2200,"price":45.85,"value":100870.0,"ownership":{"direct":true},"balance_after":227345,"source":{"system":"sec-edgar","filing":"0001179110-15-002009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002009/edgar.xml","form_type":"4"}},{"id":456080,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:12:36.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":300,"price":45.845,"value":13753.5,"ownership":{"direct":true},"balance_after":229545,"source":{"system":"sec-edgar","filing":"0001179110-15-002009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002009/edgar.xml","form_type":"4"}},{"id":456079,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:12:36.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":100,"price":45.8375,"value":4583.75,"ownership":{"direct":true},"balance_after":229845,"source":{"system":"sec-edgar","filing":"0001179110-15-002009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002009/edgar.xml","form_type":"4"}},{"id":456078,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:12:36.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":200,"price":45.835,"value":9167.0,"ownership":{"direct":true},"balance_after":229945,"source":{"system":"sec-edgar","filing":"0001179110-15-002009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002009/edgar.xml","form_type":"4"}},{"id":456077,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:12:36.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":1935,"price":45.83,"value":88681.05,"ownership":{"direct":true},"balance_after":230145,"source":{"system":"sec-edgar","filing":"0001179110-15-002009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002009/edgar.xml","form_type":"4"}},{"id":456076,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:12:36.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":100,"price":45.8275,"value":4582.75,"ownership":{"direct":true},"balance_after":232080,"source":{"system":"sec-edgar","filing":"0001179110-15-002009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002009/edgar.xml","form_type":"4"}},{"id":456075,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:12:36.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":800,"price":45.825,"value":36660.0,"ownership":{"direct":true},"balance_after":232180,"source":{"system":"sec-edgar","filing":"0001179110-15-002009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002009/edgar.xml","form_type":"4"}},{"id":456074,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:12:36.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":3900,"price":45.82,"value":178698.0,"ownership":{"direct":true},"balance_after":232980,"source":{"system":"sec-edgar","filing":"0001179110-15-002009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002009/edgar.xml","form_type":"4"}},{"id":456117,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":100,"price":45.8175,"value":4581.75,"ownership":{"direct":true},"balance_after":236880,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456116,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":500,"price":45.815,"value":22907.5,"ownership":{"direct":true},"balance_after":236980,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456115,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":4300,"price":45.81,"value":196983.0,"ownership":{"direct":true},"balance_after":237480,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456114,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":400,"price":45.8075,"value":18323.0,"ownership":{"direct":true},"balance_after":241780,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456113,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":900,"price":45.805,"value":41224.5,"ownership":{"direct":true},"balance_after":242180,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456112,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":1373,"price":45.8,"value":62883.4,"ownership":{"direct":true},"balance_after":243080,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456111,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":100,"price":45.7975,"value":4579.75,"ownership":{"direct":true},"balance_after":244453,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456110,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":1800,"price":45.795,"value":82431.0,"ownership":{"direct":true},"balance_after":244553,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456109,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":400,"price":45.79,"value":18316.0,"ownership":{"direct":true},"balance_after":246353,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456108,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":200,"price":45.7875,"value":9157.5,"ownership":{"direct":true},"balance_after":246753,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456107,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":1100,"price":45.785,"value":50363.5,"ownership":{"direct":true},"balance_after":246953,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456106,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":1600,"price":45.78,"value":73248.0,"ownership":{"direct":true},"balance_after":248053,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456105,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":100,"price":45.7775,"value":4577.75,"ownership":{"direct":true},"balance_after":249653,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456104,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":2400,"price":45.775,"value":109860.0,"ownership":{"direct":true},"balance_after":249753,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456103,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":4000,"price":45.77,"value":183080.0,"ownership":{"direct":true},"balance_after":252153,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456102,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":100,"price":45.7675,"value":4576.75,"ownership":{"direct":true},"balance_after":256153,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456101,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":3016,"price":45.765,"value":138027.24,"ownership":{"direct":true},"balance_after":256253,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456100,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":1384,"price":45.76,"value":63331.84,"ownership":{"direct":true},"balance_after":259269,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456099,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":200,"price":45.7575,"value":9151.5,"ownership":{"direct":true},"balance_after":260653,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456098,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":400,"price":45.755,"value":18302.0,"ownership":{"direct":true},"balance_after":260853,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456097,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":900,"price":45.75,"value":41175.0,"ownership":{"direct":true},"balance_after":261253,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456096,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":300,"price":45.745,"value":13723.5,"ownership":{"direct":true},"balance_after":262153,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456095,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":2900,"price":45.74,"value":132646.0,"ownership":{"direct":true},"balance_after":262453,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456094,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":700,"price":45.735,"value":32014.5,"ownership":{"direct":true},"balance_after":265353,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456093,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":5000,"price":45.73,"value":228650.0,"ownership":{"direct":true},"balance_after":266053,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456092,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":100,"price":45.7275,"value":4572.75,"ownership":{"direct":true},"balance_after":271053,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456091,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":1300,"price":45.725,"value":59442.5,"ownership":{"direct":true},"balance_after":271153,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456090,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":2300,"price":45.72,"value":105156.0,"ownership":{"direct":true},"balance_after":272453,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456089,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":100,"price":45.7175,"value":4571.75,"ownership":{"direct":true},"balance_after":274753,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456088,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:52.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":800,"price":45.715,"value":36572.0,"ownership":{"direct":true},"balance_after":274853,"source":{"system":"sec-edgar","filing":"0001179110-15-002008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002008/edgar.xml","form_type":"4"}},{"id":456150,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Option (right to buy)","published_at":"2015-02-06T22:11:29.000Z","date":"2015-02-04","kind":"exercise","acquired":false,"shares":83000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":25.2461,"exercise_date":"2010-02-16","expiration_date":"2017-02-15","underlying":"Common shares","underlying_shares":83000},"source":{"system":"sec-edgar","filing":"0001179110-15-002007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":31,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002007/edgar.xml","form_type":"4"}},{"id":456149,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:29.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":2500,"price":45.71,"value":114275.0,"ownership":{"direct":true},"balance_after":275653,"source":{"system":"sec-edgar","filing":"0001179110-15-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002007/edgar.xml","form_type":"4"}},{"id":456148,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:29.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":600,"price":45.705,"value":27423.0,"ownership":{"direct":true},"balance_after":278153,"source":{"system":"sec-edgar","filing":"0001179110-15-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002007/edgar.xml","form_type":"4"}},{"id":456147,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:29.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":2500,"price":45.7,"value":114250.0,"ownership":{"direct":true},"balance_after":278753,"source":{"system":"sec-edgar","filing":"0001179110-15-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002007/edgar.xml","form_type":"4"}},{"id":456146,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:29.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":100,"price":45.695,"value":4569.5,"ownership":{"direct":true},"balance_after":281253,"source":{"system":"sec-edgar","filing":"0001179110-15-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002007/edgar.xml","form_type":"4"}},{"id":456145,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:29.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":2600,"price":45.69,"value":118794.0,"ownership":{"direct":true},"balance_after":281353,"source":{"system":"sec-edgar","filing":"0001179110-15-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002007/edgar.xml","form_type":"4"}},{"id":456144,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:29.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":100,"price":45.6875,"value":4568.75,"ownership":{"direct":true},"balance_after":283953,"source":{"system":"sec-edgar","filing":"0001179110-15-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002007/edgar.xml","form_type":"4"}},{"id":456143,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:29.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":600,"price":45.685,"value":27411.0,"ownership":{"direct":true},"balance_after":284053,"source":{"system":"sec-edgar","filing":"0001179110-15-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002007/edgar.xml","form_type":"4"}},{"id":456142,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:29.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":2700,"price":45.68,"value":123336.0,"ownership":{"direct":true},"balance_after":284653,"source":{"system":"sec-edgar","filing":"0001179110-15-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002007/edgar.xml","form_type":"4"}},{"id":456141,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:29.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":100,"price":45.6775,"value":4567.75,"ownership":{"direct":true},"balance_after":287353,"source":{"system":"sec-edgar","filing":"0001179110-15-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002007/edgar.xml","form_type":"4"}},{"id":456140,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:29.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":900,"price":45.675,"value":41107.5,"ownership":{"direct":true},"balance_after":287453,"source":{"system":"sec-edgar","filing":"0001179110-15-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002007/edgar.xml","form_type":"4"}},{"id":456139,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:29.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":2500,"price":45.67,"value":114175.0,"ownership":{"direct":true},"balance_after":288353,"source":{"system":"sec-edgar","filing":"0001179110-15-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002007/edgar.xml","form_type":"4"}},{"id":456138,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15393,"kind":"person","name":"CAPEK JOHN M","position":1,"cik":"0001328034","reported_name":"CAPEK JOHN M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common shares without par value","published_at":"2015-02-06T22:11:29.000Z","date":"2015-02-04","kind":"sale","acquired":false,"shares":700,"price":45.665,"value":31965.5,"ownership":{"direct":true},"balance_after":290853,"source":{"system":"sec-edgar","filing":"0001179110-15-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911015002007/edgar.xml","form_type":"4"}}],"next_cursor":"2015-02-06T22:11:29.000000Z,456138"}